Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EHA 2015 | Outlook for the management of chronic myeloid leukemia

Stephen O’Brien • 12 Jun 2015
EHA 2015
Chronic Myeloid Leukemia

The management of chronic myeloid leukemia remains a significant challenge despite the introduction of effective tyrosine kinase inhibitors. At the 20th Congress of the European Hematology Association (EHA), Stephen O’Brien, BSc (Hons), PhD, MBChB, FRCP, FRCPath, of the University of Newcastle, Newcastle upon Tyne, UK, explains possible new strategies that may improve the outlook for these patients.

More from Stephen O’Brien

Engaging patients in clinical research
2:03
Engaging patients in clinical research
Stephen O’Brien • 12 Jun 2015
Adaptive licensing: A new approach for authorizing medicines
0:55
Adaptive licensing: A new approach for authorizing medicines
Stephen O’Brien • 12 Jun 2015
SPIRIT2 trial on dasatinib for AML - safety and side effect management
2:29
SPIRIT2 trial on dasatinib for AML - safety and side effect management
Stephen O’Brien • 18 Apr 2016

Related Videos

Can treatment-free remission become a reality in polycythemia vera?
1:34
Can treatment-free remission become a reality in polycythemia vera?
Ruben Mesa • 2 Oct 2026
Beyond the label: optimal dosing strategies for CML in community practice
0:51
Beyond the label: optimal dosing strategies for CML in community practice
Fadi Haddad • 10 Sep 2026
Incorporating patient goals into frontline TKI selection in CML
2:17
Incorporating patient goals into frontline TKI selection in CML
Jorge Cortes • 10 Sep 2026
Optimizing frontline therapy selection to prevent resistance in CML
1:58
Optimizing frontline therapy selection to prevent resistance in CML
Jorge Cortes • 10 Sep 2026

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals